SEC FORM 4
$222,593.92
UNITED THERAPEUTICS Corp (UTHR)
Sale of 400 shares at $556.4848 per share.
Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S
Traded Oct 7, 2026 · Disclosed Oct 8, 2026
Source: SEC Form 4 · 0001106578-26-000159 · filed 2026-10-08 · View filing →